Detailed Product Description 5-Amino-1-Methylquinolinium (5-Amino-1MQ) is a first-in-class, selective NNMT inhibitor designed for research into metabolic regulation, obesity, diabetes, nonalcoholic fatty liver disease, and age-associated muscle degeneration
The primary endpoint of the study was the number of treatment-related adverse events from baseline to the end of follow-up at 26 weeks, while the exploratory endpoints were changes in body weight, glycemic parameters, and various hormones
Heres what you should know
B12 can be stored in the body
Published laboratory research has investigated the complementary interaction between GHRH receptor stimulation and ghrelin receptor activation
Stretch the wrist extensors by gently bending your wrist downward with the elbow straight